Richie, Thomas L., Charoenvit, Yupin, Wang, Ruobing, Epstein, Judith E., Hedstrom, Richard C., Kumar, Sanjai, Luke, Thomas C., Freilich, Daniel A., Aguiar, Joao C., Sacci, Jr., John B., Sedegah, Martha, Nosek, Jr., Ronald A., De La Vega, Patricia, Berzins, Mara P., Majam, Victoria F., Abot, Esteban N., Ganeshan, Harini, Richie, Nancy O., Banania, Jo Glenna, Baraceros, Maria Fe B., Geter, Tanya, Mere, Robin, Bebris, Lolita, Limbach, Keith, Hickey, Bradley W., Lanar, David E., Ng, Jennifer, Shi, Meng, Hobart, Peter M., Norman, Jon A., Soisson, Lorraine A., Hollingdale, Michael R., Rogers, William O., Doolan, Denise L., and Hoffman, Stephen L. (2012) Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA. Human Vaccines & Immunotherapeutics, 8 (11). pp. 1564-1584.

Hedstrom, Richard C., and Doolan, Denise L. (2002) DNA vaccination. In: Doolan, Denise L., (ed.) Malaria Methods and Protocols. Methods in Molecular Medicine, 72 . Humana Press, New Jersey, NY, USA, pp. 347-360.

Wang, Ruobing, Epstein, Judith, Baraceros, Fe Maria, Gorak, Edward J., Charoenvit, Yupin, Carucci, Daniel J., Hedstrom, Richard C., Rahardjo, Nancy, Gay, Tanya, Hobart, Peter, Stout, Rick, Jones, Trevor R., Richie, Thomas L., Parker, Suezanne E., Doolan, Denise L., Norman, Jon, and Hoffman, Stephen L. (2001) Induction of CD4⁺ T cell-dependent CD8⁺ type 1 responses in humans by a malaria DNA vaccine. Proceedings of the National Academy of Sciences of the United States of America, 98 (19). pp. 10817-10822.

Le, Thong P., Coonan, Kevin M., Hedstrom, Richard C., Charoenvit, Yupin, Sedegah, Martha, Epstein, Judith E., Kumar, Sanjai, Wang, Ruobing, Doolan, Denise L., Maguire, Jason D., Parker, Suezanne E., Hobart, Peter, Norman, Jon, and Hoffman, Stephen L. (2000) Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine, 18 (18). pp. 1893-1901.

Wang, Ruobing, Doolan, Denise L., Le, Thong P., Hedstrom, Richard C., Coonan, Kevin M., Charoenvit, Yupin, Jones, Trevor R., Hobart, Peter, Margalith, Michal, Ng, Jennifer, Weiss, Walter R., Sedegah, Martha, de Taisne, Charles, Norman, Jon A., and Hoffman, Stephen L. (1998) Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science, 282 (5388). pp. 476-480.

Hoffman, Stephen L., Doolan, Denise L., Sedegah, Martha, Aguiar, Joao C., Wang, Ruobing, Malik, Anita, Gramzinski, Robert A., Weiss, Walter R., Hobart, Peter, Norman, Jon A., Margalith, Michal, and Hedstrom, Richard C. (1997) Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use. Vaccine, 15 (8). pp. 842-845.

Hedstrom, Richard C., Doolan, Denise L., Wang, Ruobing, Gardner, Malcolm J., Kumar, Anita, Sedegah, Martha, Gramzinski, Robert A., Sacci, John B., Charoenvit, Yupin, Weiss, Walter R., Margalith, Michal, Norman, Jon A., Hobart, Peter, and Hoffman, Stephen L. (1997) The development of a multivalent DNA vaccine for malaria. Springer Seminars in Immunopathology, 19 (2). pp. 147-159.

Hoffman, Stephen L., Doolan, Denise L., Sedegah, Martha, Wang, Ruobing, Scheller, Libia F., Kumar, Anita, Weiss, Walter R., Le, Thong P., Klinman, Dennis M., Hobart, Peter, Norman, Jon, and Hedstrom, Richard C. (1997) Toward clinical trials of DNA vaccines against malaria. Immunology and Cell Biology, 75. pp. 376-381.

Gardner, Malcolm J., Doolan, Denise L., Hedstrom, Richard C., Wang, Ruobing, Sedegah, Martha, Gramzinski, Robert A., Aguiar, Joao C., Wang, Helen, Margalith, Michal, Hobart, Peter, and Hoffman, Stephen L. (1996) DNA vaccines against malaria: immunogenicity and protection in a rodent model. Journal of Pharmaceutical Sciences, 85 (12). pp. 1294-1300.

Doolan, Denise L., Sedegah, Martha, Hedstrom, Richard C., Hobart, Peter, Charoenvit, Yupin, and Hoffman, Stephen L. (1996) Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon γ-, and nitric oxide-dependent immunity. The Journal of Experimental Medicine, 183 (4). pp. 1739-1746.

Hoffman, S.L., Doolan, D.L., Sedegah, M., Gramzinski, R., Wang, H., Gowda, K., Hobart, P., Margalith, M., Norman, J., and Hedstrom, R. (1995) Nucleic acid malaria vaccines. Annals of the New York Academy of Sciences, 772. pp. 88-94.